1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 08 JUNE 2015

Cancer Drug News 08 JUNE 2015

  • June 2015
  • -
  • Espicom Business Intelligence
  • -
  • 16 pages

Industry Trend Analysis - Janssen's Daratumumab Set To Enter MM Market In 2016
Industry Brief - TapImmune Gains Funding Options For Phase II Trial Programmes
Industry Brief - Amgen/Roche Enter Immuno-Oncology Trial Collaboration
Industry Trend Analysis - First-Line CLL Signifies Start Of Imbruvica Market Expansion
Industry Brief - Aptose's APTO253 Granted ODD In US For AML
Industry Brief - AVEO Receives EU Regulatory Guidance On Tivozanib MAA
Industry Brief - PharmaEngine Seeks Approval For MM-398 In Taiwan
Industry Brief - CEL-SCI Cleared To Start Multikine Phase III H&N Cancer Trial In Thailand
Industry Trend Analysis - BMS Faces Heated Battle For Position In Anti-PD-1 Space
Industry Brief - Seattle/Unum Enter Cancer Immunotherapy Collaboration
Industry Brief - Celgene/bluebird Decrease CAR-T Deal Remit
Industry Brief - Merck/Agenus Extend Immuno-Oncology Collaboration
Industry Trend Analysis - Merck's Recent Immuno-Oncology Efforts Will Increase Competitive Edge
Industry Brief - Genmab Gains License To Antibody Panel Targeting CD19 From BMS
Industry Brief - Merck Enters Immuno-Oncology Trial Collaborations With Amgen/Tesaro/Dynavax
Industry Trend Analysis - Novartis Will Make Tafinlar/Mekinist A Blockbuster
Industry Brief - Abraxis Denied Patent On Abraxane In India
Industry Trend Analysis - Global CINV Drugs Market On Course To Grow
Industry Brief - Heron Reports Positive Results From Phase III MAGIC Study Of Sustol
Industry Brief - Juno Adds Antibody Engineering Capabilities Through X-BODY Acquisition
Industry Brief - DARA Proposes Acquisition Of UK-Based Midatech Pharma

Table Of Contents

Cancer Drug News 08 JUNE 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


Download Unlimited Documents from Trusted Public Sources

Therapy and Hormone Market in South Korea

  • December 2016
    4 pages
  • Therapy  

    Hormone  

    Cancer  

  • South Korea  

View report >

Opioid Market in the US

  • December 2016
    14 pages
  • Opioid  

  • United States  

View report >

Therapy Market in Denmark - Forecast

  • December 2016
    12 pages
  • Therapy  

  • Denmark  

View report >

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.